Innovative Engine Powering Drug Discovery

Crown Bioscience’s fully integrated drug discovery capabilities increase the speed and efficiency of progressing hits to preclinical candidates. Our disease expertise and unique translational research platforms translate into successful identification of your most: robust molecules, strategic therapeutic area and indications, and more successful phase II & III clinical trials.

• Integrated discovery: centralized multidisplinary teams conducting gene-to-candidate
• Medicinal chemistry: designing and synthesizing novel drug candidates
• Structural biology: revealing protein-drug interactions by X-ray crystallography and NMR
• In silico drug discovery: accelerating drug discovery using computational technologies
• Target discovery: identifying novel targets using human primary cells
• ADME/PK: performing comprehensive ADME and pharmacokinetics
• Assay development: compound screening using tailored biochemical and cellular assays
• Unique Assets: predictive models within translational oncology and diabetes